BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Pseudomonas infection, Heart, Hematopoietic cell, Trichostatin A, rs2476601, SNCA)
Bookmark Forward

QuickView for ODC1 (gene)


Body Atlas

Most Correlated Tissues

  1. T Lymphocyte (regulatory) of peripheral blood
  2. B lymphocyte (IgM memory) of spleen
  3. Testes
  4. B lymphocyte (naive) of spleen
  5. Prostate gland
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disorder of intraocular pressure
  2. Meningitis
  3. Listeriosis
  4. Hyperoxia
  5. Viral infections of the central nervous system
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. FipA protein, Fusobacterium nucleatum
  2. GDNF protein, human
  3. F8 protein, human
  4. GSK-1059615
  5. A 443654
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR365A
  2. TCTN1
  3. GYS1
  4. CYP2C19
  5. ZNF581
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. RNAi-mediated down-regulation of ornithine decarboxylase (ODC) impedes wound-stress stimulation of a…
  2. Lysine harvesting is an antioxidant strategy and triggers underground polyamine metabolism.
  3. Emerging Role of ODC1 in Neurodevelopmental Disorders and Brain Development.
  4. Circular RNA circ_0003028 regulates cell development through modulating miR-498/ornithine decarboxyl…
  5. CDC27-ODC1 Axis Promotes Metastasis, Accelerates Ferroptosis and Predicts Poor Prognosis in Neurobla…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That i…
  2. Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
  3. Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.